Achillion Pharmaceuticals, Inc. (ACHN) Reiterates HCV Pipeline Priorities And Reports Third Quarter And Nine Month 2013 Financial Results
11/12/2013 12:51:34 PM
NEW HAVEN, Conn., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and nine months ended September 30, 2013 and provided an update on the Company's portfolio of direct-acting antiviral compounds being developed for the treatment of chronic hepatitis C virus (HCV).
Help employers find you! Check out all the jobs and post your resume.
comments powered by